Knowledge Hub

At Sterling, we are proud of our heritage, strong technical capabilities and compliance credentials but it’s our people and the genuine and passionate way they do business that makes us different.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.

At Sterling we believe that whilst science can be complex, partnerships should be simple. That is why we have prepared a range of resources to share our team’s research and expertise, and to help you learn more about Sterling and the services we offer.

Filter Content

Knowledge Hub Articles

Article

Balancing the use of hazardous chemistry in API development and manufacturing

Blog

Journey of an API: Supporting quality by design in API development

News

ADC

GlycoNex Announces Manufacturing Agreement with Sterling for GNX102-ADC Clinical Trial Production

News

Sterling Expands GMP ADC Manufacturing Capacity at Deeside, UK

Infographic

Measurement of ADC stability in plasma and serum via mass spectrometry analysis

One pager

API DevelopmentFlow Chemistry

Small molecule overview

Technologies & Services